Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 6. Click on ID to see further detail.
IDOV_3671Virus nameMeasles virusVirus strainwild typeVirus genome typeRNAVirus familyParamyxoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman eosopahgeal cancer cell lineCell lineKYSE 70Concentration of cell line5000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration1 MOIIn-vitro result70% cell viability after day 3Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedVirus in combination with induce apiptosis in cancer cellImmunogenic effectNAClinical trialNAPMID29485292
IDOV_3672Virus nameMeasles virusVirus strainwild typeVirus genome typeRNAVirus familyParamyxoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman eosopahgeal cancer cell lineCell lineKYSE 70Concentration of cell line5000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration1 MOIIn-vitro result25% cell viability after day 6Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedVirus in combination with induce apiptosis in cancer cellImmunogenic effectNAClinical trialNAPMID29485292
IDOV_3687Virus nameMumps virusVirus strainwild typeVirus genome typeRNAVirus familyParamyxoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman eosopahgeal cancer cell lineCell lineKYSE 70Concentration of cell line5000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration1 MOIIn-vitro result80% cell viability after day 3Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedVirus in combination with induce apiptosis in cancer cellImmunogenic effectNAClinical trialNAPMID29485292
IDOV_3688Virus nameMumps virusVirus strainwild typeVirus genome typeRNAVirus familyParamyxoviridaeVirus genome modificationNoneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman eosopahgeal cancer cell lineCell lineKYSE 70Concentration of cell line5000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration1 MOIIn-vitro result75% cell viability after day 6Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedVirus in combination with induce apiptosis in cancer cellImmunogenic effectNAClinical trialNAPMID29485292
IDOV_3703Virus nameMeasles and mumps virusVirus strainwild typeVirus genome typeRNAVirus familyParamyxoviridaeVirus genome modificationNoneVirus aloneNoVirus in combination with drug/radiationMeasles virus in combination with mumps virusImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman eosopahgeal cancer cell lineCell lineKYSE 70Concentration of cell line5000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration1 MOIIn-vitro result70% cell viability after day 3Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedVirus in combination with induce apiptosis in cancer cellImmunogenic effectNAClinical trialNAPMID29485292
IDOV_3704Virus nameMeasles and mumps virusVirus strainwild typeVirus genome typeRNAVirus familyParamyxoviridaeVirus genome modificationNoneVirus aloneNoVirus in combination with drug/radiationMeasles virus in combination with mumps virusImmune gene insertion in viral genomeNoSource of cell lineATCCOrigin of cell lineHuman eosopahgeal cancer cell lineCell lineKYSE 70Concentration of cell line5000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration1 MOIIn-vitro result30% cell viability after day 6Model organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedVirus in combination with induce apiptosis in cancer cellImmunogenic effectNAClinical trialNAPMID29485292